US Patent

US10751305 — Solid-forming topical formulations for pain control

Formulation · Assigned to Crescita Therapeutics Inc · Expires 2031-01-14 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects solid-forming topical formulations for pain control that can include a local anesthetic, emulsifying agent, polymer, and water.

USPTO Abstract

Solid-forming topical formulations can include a local anesthetic, an emulsifying agent, polymer, and water. The formulation can include from 0.1 wt % to 5 wt % more of the emulsifying agent, from 0.1 wt % to 20 wt % more of the polymer, and from 0.1 wt % to 30 wt % more water than a comparative formulation, and drying time is faster than the comparative formulation when applied to a skin surface and dried under the same ambient conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US10751305
Jurisdiction
US
Classification
Formulation
Expires
2031-01-14
Drug substance claim
No
Drug product claim
Yes
Assignee
Crescita Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.